Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Fine Chemicals. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108821966B reveals a high-yield, non-toxic route for 3,3'-(1,4-phenylene) diglutaric acid using ethyl acetoacetate, offering significant cost reduction.
Patent CN116640077B reveals metal-free synthesis of 1,1-diseleno olefins. Offers cost reduction and supply chain reliability for high-purity organoselenium intermediates.
Patent CN113185478A reveals a novel ethylenediamine-based route for N-Boc-piperazine, offering superior purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN103333171B reveals a high-yield, transition-metal-free synthesis for pyrrole[1,2-a]quinoxaline derivatives, offering cost-effective manufacturing solutions.
Patent CN110590854A reveals a stable triazole carbene palladium catalyst enabling high-yield Suzuki coupling with reduced operational costs and scalable supply chain reliability.
Patent CN110698360A details a green visible-light method for amide synthesis. Discover cost-effective, metal-free manufacturing solutions for high-purity pharmaceutical intermediates.
Patent CN103910657A reveals metal bromide catalysis for aziridine ring opening, offering cost reduction and high regioselectivity for supply chain stability.
Novel nickel-catalyzed synthesis of beta-iododifluoroacetone derivatives offers high yield and scalability for pharmaceutical intermediates manufacturing supply chain cost reduction.
Patent CN115057808A reveals a green Rh-catalyzed method for Z-isoindolinones. High stereoselectivity, no oxidants. Ideal for pharma intermediates supply.
Advanced copper-catalyzed synthesis of 4-phenylcoumarin intermediates. Eco-friendly, high-yield process for pharmaceutical and fine chemical manufacturing supply chains.
Patent CN106831603B reveals metal-free visible light synthesis for fluoropyrimidines, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113773227A details a visible-light mediated method for epsilon-cyano carboxylic acids using CO2. Offers cost-effective pharma intermediate manufacturing.
Novel metal-free synthesis of indoline derivatives via Kukhtin-Ramirez adduct. High yield, mild conditions, scalable for API intermediates and fine chemicals.
Patent CN111170918A details a cost-effective iridium-catalyzed C-H amination route for lactams, offering significant supply chain stability and reduced manufacturing costs for pharma intermediates.
Patent CN114075108A details a metal-free visible light method for aldehyde deuteration, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Patent CN102781948A details stable P-chiral aminodiphosphine ligands enabling high-ee asymmetric hydrogenation for cost-effective chiral pharmaceutical intermediates manufacturing.
Patent CN111574487B details a novel asymmetric hydrogenation method for producing high-purity chiral dihydroisoflavones, offering significant supply chain and cost advantages.
Novel beta-site nucleophilic substitution method disclosed in patent. High selectivity, mild conditions. Reliable supply chain for fluorine intermediates manufacturing.
Patent CN101665450B details a novel selenium-catalyzed one-pot synthesis of Schiff bases from nitro compounds, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN114436912A reveals a cinchona-catalyzed route for carbon-nitrogen axis chiral sulfonamides. Achieves high enantioselectivity and yield under mild conditions for cost-effective manufacturing.